Skip to main content

Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources

Written by Customer Service on . Posted in Public Companies.

Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams

CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the appointment of Brikkelle Thompson as senior vice president of human resources. Ms. Thompson brings nearly 25 years of visionary human resources leadership, global experience, and deep talent management to Lifecore, including 14 years in the medical technology, medical device, and healthcare industries. She will be charged with enhancing the company’s performance-driven culture, while further strengthening the Lifecore team by maintaining and securing exceptional talent.

“As we continue to sharpen and execute our growth strategy to maximize value for our stakeholders, we are keenly aware that our corporate culture and team will be essential to successfully achieving our vision for the business. In Brikkelle, we have added an exceptional HR executive who has a well-earned reputation for elevating companies by building teams with top-level talent from across the country while fostering performance-driven cultures,” said Paul Josephs, president and chief executive officer. “We feel fortunate to add Brikkelle as a strategic partner to our operations team and are eager to see the important contributions she makes in aligning our mission, values, culture, and team toward our ultimate goal of consistent and meaningful growth.”

Ms. Thompson has a successful track record of partnering with organizational leaders to architect and deliver HR strategies to optimize the employee experience and enhance organizational performance. Her leadership spans from small organizations to Fortune 100 companies in public and private sectors. Prior to joining Lifecore, she held the position of head of human resources – the Americas at Teleflex. Ms. Thompson has also served as vice president of human resources for Nonin Medical, where she reported directly into the CEO and instituted an HR Business Partner model that positioned HR as the strategic, proactive and collaborative partner to company-wide leadership. Her career also includes nearly a decade tenure with Medtronic, where she held the position of global executive development program manager, as well as serving as talent development consultant.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the Company, visit Lifecore’s website at www.lifecore.com.

CONTACT: Lifecore Biomedical, Inc. Contact Information:

Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com

Tim Brons (Media)
415-675-7402
tbrons@vidasp.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.